Respiratory system involvement in ANCA-associated systemic vasculitides

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue SUPPL. 1, 2005, Pages

  Pesci, Alberto ^a,c   Pavone, Laura ^a   Buzio, Carlo ^a   Manganelli, Paolo ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c Ospedale Rasori   (Italy)

Author keywords

Antineutrophil cytoplasmic antibodies; High resolution computed tomography; Respiratory system; Systemic vasculitides

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED VASCULITIS; CHURG STRAUSS SYNDROME; CONFERENCE PAPER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG DISEASE; LUNG FUNCTION TEST; LUNG INFILTRATE; LUNG NODULE; NOSE POLYP; PRIORITY JOURNAL; RARE DISEASE; SYSTEMIC VASCULITIS; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, NEEDLE; BRONCHOALVEOLAR LAVAGE FLUID; CHURG-STRAUSS SYNDROME; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 31544439402     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (72)

1. Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978; 89: 660-76.
2. nd Ed. London: Mosby 1998; 7: 1-8.
3. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.
4. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
5. Hunder GG, Arend WP, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33: 1065-7.
6. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
7. Hoffman GS, Kerr GS, Leavitt RY, et al: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992: 116: 488-98.
8. Stone JH: Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum 2003; 48: 2299-309.
9. Reinhold-Keller E, Beuge N, Latza U, et al: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-32.
10. Daum TE, Specks U, Colby TV, et al: Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 1995; 151: 522-6.
11. Langford CA, Sneller MC, Hallahan CW, et al: Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 1996; 39: 1754-60.
12. Bambery P, Sakhuja V, Behera D, Deodhar SD: Pleural effusions in Wegener's granulomatosis: report of five patients and a brief review of the literature. Scand J Rheumatol 1991; 20: 445-7.
13. Schwartz MI, Brown KK: Small vessel vasculitis of the lung. Thorax 2000; 55: 502-10.
14. Bosch X, López-Soto A, Mirapeix E, Font J, Ingelmo M, Urbano-Márquez A: Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary haemorrhage. Arch Pathol Lab Med 1994; 118: 517-22.
15. Ter Maaten JC, Franssen CFM, Gans ROB, van Schijndel RJM, Hoorntje SJ: Respiratory failure in ANCA-associated vasculitis. Chest 1996; 110: 357-62.
16. Rosenberg DM, Weinberger SE, Fulmer JD, Flye MW, Fauci AS, Crystal RG: Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 1980; 69: 387-94.
17. Aberle DR, Gamsu G, Lynch D: Thoracic manifestations of Wegener's granulomatosis: diagnosis and course. Radiology 1990; 174: 703-9.
18. Papiris SA, Manoussakis MN, Drosos AA, Kontogiannis D, Constantopoulos SH, Moutsopoulos HM: Imaging of thoracic Wegener's granulomatosis: the computed tomographic appearance. Am J Med 1992; 93: 529-36.
19. Seo JB, Im JG, Chung JW, et al: Pulmonary vasculitis: the spectrum of radiological findings. Br J Radiol 2000; 73: 1224-31.
20. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM: Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest 1990; 97: 906-12.
21. Rockall AG, Rickards D, Shaw PJ: Imaging of the pulmonary manifestations of systemic disease. Postgrad Med J 2001; 77: 621-38.
22. Kuhlman JE, Hruban RH, Fishman EK: Wegener's granulomatosis: CT features of parenchymal lung disease. J Comput Assist Tomogr 1991; 15: 948-52.
23. Primack SL, Hartman TE. Lee KS, Müller NL: Pulmonary nodules and the CT halo sign. Radiology 1994; 190: 513-15.
24. Lee SK, Kim TS, Fujimoto K, et al: Thoracic manifestations of Wegener's granulomatosis: CT findings in 30 patients. Eur Radiol 2003; 13: 43-51.
25. George TM, Cash JM, Farver C, et al: Mediastinal mass and hilar adenopathy. Rare thoracic manifestations of Wegener's granulomatosis. Arthritis Rheum 1997; 40: 1992-7.
26. Reuter M, Schnabel A, Wesner F, et al: Pulmonary Wegener's granulomatosis. Correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 1998; 114: 500-6.
27. Komocsi A, Reuter M, Heller M, Muraközi H, Gross WL, Schnabel A: Active disease and residual damage in treated Wegener's granulomatosis: an observational study using pulmonary high resolution computed tomography. Eur Radiol 2003; 13: 36-42.
28. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS: Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991; 19: 315-33.
29. Gaudin PB, Askin FB, Falk RJ, Jennette JC: The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for antiproteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995; 104: 7-16.
30. Devankey KO, Travis WD, Hoffman G, et al: Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990; 14: 555-64.
31. Hoffman GS, Sechler JMG, Gallin JI, et al: Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis 1991; 143: 401-7.
32. Schnabel A, Csernok E, Gross WL: Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosis. Am J Respir Crit Care Med 2000; 161: 399-405.
33. Schnabel A, Reuter M, Gloeckner K, Muller-Quernheim J, Gross WL: Bronchoalveolar lavage cell profile in Wegener's granulomatosis. Respir Med 1999; 93: 498-506.
34. Csernok E, Trabandt A, Muller A, et al: Cytokine profile in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999; 42: 742-50.
35. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL: Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J 1999; 14: 118-24.
36. Lanham JC, Elkon KB, Pusey CD, Hughes GR: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984; 63: 65-81.
37. Masi AT, Hunder GG, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
38. Abril A, Calamia KT, Cohen MD: The Churg-Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 2003; 33: 106-14.
39. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999; 78: 26-37.
40. Chumbley LC, Harrison EC Jr, DeRemee RA: Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977; 52: 477-84.
41. Haas C, Geneau C, Odinot JM, et al: Allergic angiitis and granulomatosis: Churg-Strauss syndrome. Retrospective study of 16 cases. Ann Méd Interne 1991; 142: 335-42.
42. Keogh KA, Specks U: Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003; 115: 284-90.
43. Tawil A, Diab K, Arayssi T: Leukotriene antagonists and the Churg-Strauss syndrome. Semin Arthritis Rheum 2002; 31: 218-27.
44. Weller PF, Plaut M, Taggart Y, Trontell A: The relationship of asthma and Churg-Strauss syndrome: NHI workshop summary report. J Allergy Clin Immunol 2001; 108: 175-83.
45. Le Gall C, Pham S, Vignes S, et al: Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Eur Respir J 2000; 15: 978-81.
46. Cooper SM, Libman BS, Lazarovich M: Churg-Strauss syndrome in a group of patients receiving fluticasone for asthma. J Rheumatol 2002; 29: 2651-2.
47. Solans R, Bosch JA, Pérez-Bocanegra C, et al: Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001; 40: 763-71.
48. Clutterbuck EJ, Pusey CD: Severe alveolar haemorrhage in Churg-Strauss syndrome. Eur J Respir Dis 1987; 71: 158-63.
49. Lai R-S, Lin S-L, Lai N-S. Lee P-C: Churg-Strauss syndrome presenting with pulmonary capillaritis and diffuse alveolar hemorrhage. Scand J Rheumatol 1998; 27: 230-2.
50. Della Rossa A, Baldini C, Tavoni A, et al: Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology 2002; 41: 1286-94.
51. Erzurum SC, Underwood GA, Hamilos DL, Waldron JA: Pleural effusion in Churg-Strauss syndrome. Chest 1989; 95: 1357-9.
52. Hirasaki S, Kamei T, Iwasaki Y, et al: Churg-Strauss syndrome with pleural involvement. Intern Med 2000; 39: 976-8.
53. Choi YH, Im J-G, Han BK, Kim J-H, Lee KY, Myoung NH: Thoracic manifestation of Churg-Strauss syndrome. Radiologic and clinical findings. Chest 2000; 117: 117-24.
54. Worthy SA, Müller NL, Hansell DM, Flower CD: Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. Am J Roengtenol 1998; 170: 297-300.
55. Buschman DL, Waldron JA, King TE: Churg-Strauss pulmonary vasculitis. High resolution CT scanning and pathologic findings. Am Rev Respir Dis 1990; 142: 458-61.
56. Katzenstein AL: Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol 2000; 114: 767-72.
57. Churg J, Strauss L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-94.
58. Olivieri D, Pesci A, Bertorelli G: Eosinophilic alveolitis in immunologic interstitial lung disorders. Lung 1990; (Suppl): 964-73.
59. Wallaert B, Gosset P, Prin L, Bart F, Marquette C-H, Tonnel AB: Bronchoalveolar lavage in allergic granulomatosis and angiitis. Eur Respir J 1993; 6: 413-17.
60. Schnabel A, Csernok E, Braun J, Gross WL: Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax 1999; 54: 771-8.
61. Manganelli P, Giacosa R, Fietta P, Zanetti A, Neri MT: Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in two first-degree relatives. J Rheumatol 2003; 30: 618-21.
62. Clutterbuck EJ, Pusey CD: Severe alveolar hemorrhage in Churg-Strauss syndrome. Eur J Respir Dis 1987; 71: 158-63.
63. Lai RS, Lin SL, Lai NS, Lee PC: Churg-Strauss syndrome presenting with pulmonary capillaritis and diffuse alveolar hemorrhage. Scand J Rheumatol 1998; 27: 230-2.
64. Lauque D, Cadranel J, Lazor R, et al: Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine 2000; 79: 222-33.
65. Guillevin L, Durant-Gasselin B, Cevallos R, et al: Microscopic polyangiitis. Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30.
66. Hogan SL, Nachman PU, Wilkman AS, et al: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32.
67. Schwarz MI, Mortenson RL, Colby TV, et al: Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis 1993; 148: 507-11.
68. Brugiere O, Raffy O, Sleiman C, et al: Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med 1997; 155: 739-42.
69. Becker-Merok A, Nessent JC, Ritland N: Fibrosing alveolitis predating microscopic polyangiitis. Scand J Rheumatol 1999; 28: 254-6.
70. Eschun GM, Mink SN, Sharma S: Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003; 123: 297-301.
71. Ando Y, Okada F, Matsumoto S, Mori H: Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease: CT findings in 51 patients. J Comput Assist Tomogr 2004; 28: 710-16.
72. Akikusa B, Condo Y, Irabu N, Yamamoto S, Saiki S: Six cases of microscopic polyarteritis exhibiting acute interstitial pneumonia. Pathol Int 1995; 45: 580-8.